A moderately long-acting mydriatic and cycloplegic for cycloplegic refraction and in the treatment of inflammatory conditions of the uveal tract. For pre and postoperative states when mydriasis is required.

This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA.

It may take some time to load the article after you tap to read more.

Tap here to know more......

DailyMed (which is maintained by National Library of Medicine)